📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Nitazenes-heralding a second wave for the UK drug-related death crisis? (2024)

First Author: Holland A

Attributed to: The ReSPect Study - Reducing stigma towards people with issues related to drug use funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2468-2667(24)00001-x

PubMed Identifier: 38224702

Publication URI: http://europepmc.org/abstract/MED/38224702

Type: Journal Article/Review

Volume: 9

Parent Publication: The Lancet. Public health

Issue: 2